- Market Capitalization, $K 2,516,712
- Shares Outstanding, K 86,307
- Annual Sales, $ 1,734 M
- Annual Income, $ -796,490 K
- 60-Month Beta 2.18
- Price/Sales 1.48
- Price/Cash Flow 26.83
- Price/Book 3.30
|Period||Period Low||Period High||Performance|
| || |
-3.45 (-10.59%)since 08/17/21
| || |
-2.37 (-7.52%)since 06/17/21
| || |
+10.62 (+57.34%)since 09/17/20
Mednax, Inc. (NYSE: MD) today announced that it will present on Wednesday, September 15, 2021 at 12:30 p.m. ET to investors attending Morgan Stanley's 19th Annual Global Healthcare Conference, taking place...
MEDNAX's (MD) Q2 results reflect solid volumes, partly offset by escalating expenses.
Mednax (MD) delivered earnings and revenue surprises of 24.24% and 3.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
SUNRISE, Fla. (AP) _ Mednax Inc. (MD) on Friday reported second-quarter net income of $35 million, after reporting a loss in the same period a year earlier.
Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.36 per share for the three months...
Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Humana's (HUM) second-quarter earnings results to reflect a steep expense level, partly offset by better revenues.
HCA Healthcare's (HCA) Q2 earnings gain traction from higher revenues and improved admissions.
HCA Healthcare's (HCA) second-quarter earnings are likely to have gained from better revenues.
Mednax (MD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings...
|Direxion Connected Consumer ETF|
|S&P Smallcap Health Care Invesco ETF|
|S&P Healthcare Services SPDR|
|DWA Healthcare Momentum Invesco ETF|
|US Healthcare Providers Ishares ETF|
|3rd Resistance Point||30.63|
|2nd Resistance Point||30.31|
|1st Resistance Point||29.74|
|1st Support Level||28.85|
|2nd Support Level||28.53|
|3rd Support Level||27.96|